PVT1

 

Full name: Pvt1 oncogene Alias Symbol: NCRNA00079|LINC00079|onco-lncRNA-100|MIR1204HG
Type: non-coding RNA Cytoband: 8q24.21
Entrez ID: 5820 HGNC ID: HGNC:9709 Ensembl Gene: ENSG00000249859 OMIM ID: 165140
Drug and gene relationship at DGIdb

 

Expression of PVT1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE53622 PVT1 5820 118575 0.8299 0.0000
GSE53624 PVT1 5820 118575 0.5895 0.0000
GSE97050 PVT1 A_21_P0005951 0.9871 0.1400
SRP007169 PVT1 5820 RNAseq 0.0886 0.8438
SRP008496 PVT1 5820 RNAseq 0.1712 0.5805
SRP064894 PVT1 5820 RNAseq 1.1518 0.0000
SRP133303 PVT1 5820 RNAseq 0.5672 0.0049
SRP159526 PVT1 5820 RNAseq 0.5918 0.0082
SRP193095 PVT1 5820 RNAseq 0.8353 0.0000
SRP219564 PVT1 5820 RNAseq 0.9167 0.0665
TCGA PVT1 5820 RNAseq 1.1632 0.0000

Upregulated datasets: 2; Downregulated datasets: 0.  


 

Survival by PVT1 expression:

 

GSE53622GSE53624TCGA

 

Note: Click image to view full size file.  


Copy number change of PVT1:

 

Dataset Gene EntrezID Gain Loss Normal Detail
GSE15526 PVT1 5820 21 0 9
GSE20123 PVT1 5820 21 0 9
GSE43470 PVT1 5820 23 0 20
GSE46452 PVT1 5820 30 0 29
GSE47630 PVT1 5820 24 0 16
GSE54993 PVT1 5820 1 24 45
GSE54994 PVT1 5820 41 0 12
GSE60625 PVT1 5820 0 7 4
GSE74703 PVT1 5820 19 0 17
GSE74704 PVT1 5820 14 0 6
TCGA PVT1 5820 69 2 25

Total number of gains: 263; Total number of losses: 33; Total Number of normals: 192.  


 

Somatic mutations of PVT1:

 

Generating mutation plots.

 

Highly correlated genes for PVT1:

 

Showing top 20/88 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
PVT1MTIF20.731654303
PVT1TOP2A0.729764303
PVT1CDCA70.719162303
PVT1TROAP0.71133303
PVT1RAVER10.701872303
PVT1ATXN2L0.696788303
PVT1TAS2R430.695063303
PVT1MAZ0.691733303
PVT1SLC19A10.689326303
PVT1RBBP50.684687303
PVT1SLC38A60.677376303
PVT1ASPM0.674116303
PVT1MYBL20.674001303
PVT1SLC12A80.670035303
PVT1LMNB20.669181303
PVT1FAM111B0.667089303
PVT1SPDYE30.665942303
PVT1LEPR0.665542303
PVT1HELLS0.664524303
PVT1SPDYE10.663579303

For details and further investigation, click here